Arkolith/Insider Trading/TBPH/Form 4

Farnum Rhonda

SVP, COMM & MEDICAL AFFAIRSTheravance Biopharma, Inc. (TBPH) · full profile →Form 4 · filed Jun 17, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$218K
Net Open-Market Flow
-$218K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 15, 2026Sell(S)3K$16.39$55K242K
Jun 15, 2026Sell(S)3K$16.38$55K239K
Jun 15, 2026Sell(S)7K$16.39$109K232K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001898490-26-000010) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for Theravance Biopharma, Inc.

Build

Ask your agent about TBPH insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001898490-26-000010"
Ask your agent
Use Arkolith to summarize insider buying and selling at Theravance Biopharma, Inc.
over the last 90 days and cite the filings.